Life Science Analytics Market to hit USD 31.6 billion by 2032, says Global Market Insights Inc.

Life science analytics industry is projected to witness a CAGR of 8.2% during the period 2024-2032. This growth can be attributed to the growing adoption of analytical solutions in clinical trials.


Selbyville, Delaware, Sept. 30, 2024 (GLOBE NEWSWIRE) --

Life Science Analytics Market size was valued at USD 15.7 billion in 2023 and is projected to grow at a CAGR of 8.2% from 2024 to 2032, fueled by the demand for personalized medicines.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/11045

One key driver is the increasing use of analytical solutions in clinical trials, addressing the growing complexity of clinical research. These solutions provide real-time insights, refine trial designs, and enhance decision-making, leading to more efficient outcomes. For example, a 2023 study by Pharma Intelligence found that 65% of clinical trial sponsors using advanced analytics saw a 25% boost in trial efficiency, including quicker patient recruitment and more precise data analysis.

Technological innovations are enhancing the efficiency of life science analytics market. AI and machine learning integration refines predictive modeling and data interpretation, allowing meticulous analysis of vast datasets and revealing patterns that influence drug development and personalized treatment strategies.

The overall life science analytics industry is classified based on component, type, application, deployment mode, end-use, and region.

The services segment led the life science analytics market with a revenue of USD 9.1 billion in 2023. Life sciences companies seek bespoke analytics solutions tailored to their research demands, regulatory standards, and data intricacies. Service providers design, implement, and manage these solutions, offering continuous support, updates, and maintenance to ensure optimal performance.

In 2023, the sales and marketing support segment topped the revenue charts with USD 3.6 billion. Life sciences firms rely on analytics to gauge market trends, understand customer behavior, and assess competitive dynamics. Insights from sales and marketing analytics empower companies to craft targeted marketing strategies, refine sales approaches, and spot emerging market opportunities. Personalized, data-driven marketing enhances customer engagement and boosts conversion rates.

In 2023, North America dominated the life science analytics market with a revenue of USD 6.7 million and is projected to grow at a CAGR of 7.7% from 2024 to 2032. The region's advanced healthcare infrastructure facilitates the adoption of cutting-edge analytics solutions, allowing healthcare providers and life sciences firms to harness data analytics for better decision-making and patient outcomes. North America's substantial investments in R&D, especially in biotechnology and pharmaceuticals, amplify the demand for analytics tools that foster innovation and streamline drug development.

Request for Report Customization @ https://www.gminsights.com/roc/11045

Major players in life science analytics market include Accenture, Analytics8, Cognizant, IBM Corporation, IQVIA Inc., MaxisIT, Microsoft, Optum, Inc., Oracle Corporation, SAS Institute, Inc., Sisense Ltd., ThoughtSpot Inc., Veeva Systems, Veradigm LLC and Wipro Limited. among others.

Partial Table of Contents (ToC) of the report:

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 360-degree synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Growing adoption of analytical solutions in clinical trials

3.2.1.2    Rising demand for personalized medicines

3.2.1.3    Increasing penetration of analytics in life science industry

3.2.1.4    Rise in technological advancements in analytical solutions

3.2.2    Industry pitfalls & challenges

3.2.2.1    High implementation cost

3.2.2.2    Data privacy and theft issues

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Innovation landscape

3.6    Start-up scenario

3.7    Porter's analysis

3.8    PESTEL analysis

3.9    Future market trends

3.10    Gap analysis

Browse more artificial intelligence industry reports @ https://www.gminsights.com/industry-reports/artificial-intelligence/82

About Global Market Insights

Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

 

Kontaktdaten